首站-论文投稿智能助手
典型文献
The structure of Crimean-Congo hemorrhagic fever virus Gc is revealed;many more still need an answer
文献摘要:
Crimean-Congo hemorrhagic fever virus(CCHFV)is regarded as one of the most deadly viruses,with mortality of up to 40%.Currently,no licensed vaccine with validated efficacy against CCHFV is available.CCHFV uses Gn and Gc glycoproteins to bind and penetrate the cell,like other bunyaviruses(Hulswit et al.,2021).Thus,the desired vaccines are needed,to elicit a potent neutralizing antibody(NAb)response to counteract this process.The only target for NAb recognition is Gc,a typical type Ⅱ membrane fusion protein like flavivirus E protein(Modis et al.,2003).However,the administration of NAb targeting CCHFV Gc after one day post-challenge cannot provide protection in a lethal murine model(Fels et al.,2021).
文献关键词:
作者姓名:
Wei Ye;Chuantao Ye;Yongliang Hu;Yangchao Dong;Yingfeng Lei;Fanglin Zhang
作者机构:
Department of Microbiology,School of Preclinical Medicine,Airforce Medical University:Fourth Military Medical University,Xi'an,710032,China;Department of Infectious Diseases,Tangdu Hospital,Airforce Medical University:Fourth Military Medical University,Xi'an,710038,China;Department of Dermatology,The Eighth Medical Center of PLA General Hospital,Beijing,100091,China
文献出处:
引用格式:
[1]Wei Ye;Chuantao Ye;Yongliang Hu;Yangchao Dong;Yingfeng Lei;Fanglin Zhang-.The structure of Crimean-Congo hemorrhagic fever virus Gc is revealed;many more still need an answer)[J].中国病毒学,2022(04):634-636
A类:
bunyaviruses,Hulswit,Modis,Fels
B类:
structure,Crimean,Congo,hemorrhagic,fever,Gc,revealed,many,more,still,answer,CCHFV,regarded,as,one,most,deadly,mortality,up,Currently,licensed,validated,efficacy,against,available,Gn,glycoproteins,bind,penetrate,cell,like,other,Thus,desired,vaccines,are,needed,elicit,potent,neutralizing,antibody,NAb,response,counteract,this,process,only,recognition,typical,type,membrane,fusion,flavivirus,However,administration,targeting,after,day,post,challenge,cannot,provide,protection,lethal,murine,model
AB值:
0.555385
相似文献
Identification of circRNA/miRNA/mRNA regulatory net-work involving(+)-catechin ameliorates diabetic nephropathy mice
Chao Chen;Dina Zhu;Shuai Zhang;Wensheng Zhang-Zhuhai Branch of State Key Laboratory of Earth Surface Processes and Resource Ecology,Advanced Institute of Natural Sciences,Beijing Normal University,Zhuhai 519087,China;Engineering Research Center of Natural Medicine,Ministry of Education,Advanced Insti-tute of Natural Sciences,Beijing Normal University,Zhuhai 519087,China;International Cooperation Laboratory of Molecular Medicine,Academy of Chinese Medical Sciences,Zhejiang Chinese Medical University,Hangzhou 310053,China;Beijing Key Laboratory of Traditional Chinese Medicine Protection and Utilization,Faculty of Geographical Science,Beijing Normal University,Beijing 100875,China
Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
Hezhen Shan;Lingling Geng;Xiaoyu Jiang;Moshi Song;Jianxun Wang;Zunpeng Liu;Xiao Zhuo;Zeming Wu;Jianli Hu;Zhejun Ji;Si Wang;Piu Chan;Jing Qu;Weiqi Zhang;Guang-Hui Liu-State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;School of Life Sciences,Beijing University of Chinese Medicine,Beijing 100029,China;Advanced Innovation Center for Human Brain Protection,National Clinical Research Center for Geriatric Disorders,Xuanwu Hospital Capital Medical University,Beijing 100053,China;Aging Translational Medicine Center,Xuanwu Hospital,Capital Medical University,Beijing 100053,China;University of Chinese Academy of Sciences,Beijing 100049,China;Beijing Institute for Stem Cell and Regenerative Medicine,Beijing 100101,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing 100101,China;CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences,Beijing 100101,China;China National Center for Bioinformation,Beijing 100101,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing 100101,China;Sino-Danish College,University of Chinese Academy of Sciences,Beijing 101408,China
An ultrapotent pan-β-coronavirus lineage B(β-CoV-B)neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope
Zezhong Liu;Wei Xu;Zhenguo Chen;Wangjun Fu;Wuqiang Zhan;Yidan Gao;Jie Zhou;Yunjiao Zhou;Jianbo Wu;Qian Wang;Xiang Zhang;Aihua Hao;Wei Wu;Qianqian Zhang;Yarning Li;Kaiyue Fan;Ruihong Chen;Qiaochu Jiang;Christian T.Mayer;Till Schoofs;Youhua Xie;Shibo Jiang;Yumei Wen;Zhenghong Yuan;Kang Wang;Lu Lu;Lei Sun;Qiao Wang-Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),School of Basic Medical Sciences;Shanghai Institute of Infectious Disease and Biosecurity;the Fifth People's Hospital of Shanghai;Shanghai Key Laboratory of Medical Epigenetics,International Co-laboratory of Medical Epigenetics and Metabolism(Ministry of Science and Technology);Institutes of Biomedical Sciences;Biosafety Level 3 Laboratory,Shanghai Medical College,Fudan University,Shanghai 200032,China;CAS Key Laboratory of Infection and Immunity,National Laboratory of Macromolecules,Institute of Biophysics,Chinese Academy of Sciences,Beijing 100101,China;Experimental Immunology Branch,Center for Cancer Research,National Cancer Institute,National Institutes of Health,Bethesda,MD 20892,USA;GSK Vaccines,1300 Wavre,Belgium
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters
Yong-Qiang Deng;Na-Na Zhang;Yi-Fei Zhang;Xia Zhong;Sue Xu;Hong-Ying Qiu;Tie-Cheng Wang;Hui Zhao;Chao Zhou;Shu-Long Zu;Qi Chen;Tian-Shu Cao;Qing Ye;Hang Chi;Xiang-Hui Duan;Dan-Dan Lin;Xiao-Jing Zhang;Liang-Zhi Xie;Yu-Wei Gao;Bo Ying;Cheng-Feng Qin-State Key Laboratory of Pathogen and Biosecurity,Beijing Institute of Microbiology and Epidemiology,AMMS,Beijing,China;School of Medicine,Tsinghua University,Beijing,China;Kunming University of Science and Technology,Kunming,Yunnan,China;Suzhou Abogen Biosciences Co.,Ltd,Suzhou,Jiangsu,China;Key laboratory of Jilin Province for Zoonosis Prevention and Control,Changchun,Jilin,China;Beijing Protein and Antibody R&D Engineering Center,Sinocelltech Ltd,Beijing,China
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
Wei Pang;Ying Lu;Yan-Bo Zhao;Fan Shen;Chang-Fa Fan;Qian Wang;Wen-Qiang He;Xiao-Yan He;Ze-Kai Li;Tao-Tao Chen;Cui-Xian Yang;You-Zhi Li;Si-Xuan Xiao;Zu-Jiang Zhao;Xu-Sheng Huang;Rong-Hua Luo;Liu-Meng Yang;Mi Zhang;Xing-Qi Dong;Ming-Hua Li;Xiao-Li Feng;Qing-Cui Zhou;Wang Qu;Shibo Jiang;Songying Ouyang;Yong-Tang Zheng-Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province,KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,Yunnan,China;University of the Chinese Academy of Sciences,Beijing,China;The Key Laboratory of Innate Immune Biology of Fujian Province,Provincial University Key Laboratory of Cellular Stress Response and Metabolic Regulation,Biomedical Research Center of South China,Key Laboratory of OptoElectronic Science and Technology for Medicine of Ministry of Education,College of Life Sciences,Fujian Normal University,Fuzhou,Fujian,China;Division of Animal Model Research,Institute for Laboratory Animal Resources,National Institutes for Food and Drug Control,Beijing,China;Key Laboratory of Medical Molecular Virology(MOE/NHC/CAMS),Shanghai Institute of Infectious Disease and Biosecurity,School of Basic Medical Sciences,Fudan University,Shanghai,China;Yunnan Provincial Infectious Disease Hospital,Kunming,Yunnan,China;Kunming National High-level Biosafety Research Center for Non-human Primates,Center for Biosafety Mega-Science,Kunming Institute of Zoology,Chinese Academy of Sciences,Kunming,Yunnan,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。